Eric Topol

New report of a nasal vaccine SARS-CoV-2 booster provides strong, durable cross-variant protection—preventing infection— compared with shots in non-human primates
https://www.nature.com/articles/s41590-024-01951-5

(Medien: 1)

One of these epidemic curves is unlike all the others
Carl Bergstrom and Bill Hanage in PNAS today explain why
http://carlbergstrom.com/publications/pdfs/2023PNAS.pdf

(Medien: 1)

Some good news, folks, on the booster (XBB.1.5). It induces robust levels of neutralizing antibodies vs JN.1
https://biorxiv.org/content/10.1101/2023.11.26.568730v1
All the more reason to get it if you haven't already. JN.1 will likely become dominant here by the holidays

(Medien: 1)

A telling graph
US life expectancy by state vs countries https://www.nytimes.com/2023/08/16/opinion/health-care-life-expectancy-poverty.html?searchResultPosition=1

(Medien: 1)

Truth.

(Medien: 1)

Stopping routine hospital admission Covid testing
was associated with significant increases in hospital-onset SARS-CoV-2 infectionshttps://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2805585

(Medien: 1)